Skip to main content
Equibles

VIRTUS ADVISERS, LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1587281 HARTFORD, CT
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,122,914
+$166,314 QoQ
Shares Held
44,384
+3.3% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#147
of 353 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 7% Shared 93% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VIRTUS ADVISERS, LLC holds $9,774,150 across 19 Biotechnology names. ACAD ranks #1 (11.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ACAD
Acadia Pharmaceuticals Inc
This page 		44,384 $1,122,914
2 HRMY
Harmony Biosciences Holdings, Inc.
 29,253 $1,065,101
3 EXEL
Exelixis, Inc.
 14,769 $803,581
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 9,249 $753,885
5 INVA
Innoviva, Inc.
 30,614 $695,243
6 VCEL
Vericel Corp
 15,570 $692,709
7 ROIV
Roivant Sciences Ltd.
 18,007 $637,267
8 SRPT
Sarepta Therapeutics, Inc.
 27,098 $486,950

All Filings in ACAD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,122,914 44,384
2026-03-31 $956,600 42,974
2025-12-31 $1,147,834 42,974
2025-09-30 $917,064 42,974
2025-06-30 $926,948 42,974
2025-03-31 $713,797 42,974
2024-12-31 $371,734 20,258
2024-09-30 $335,683 21,826
2024-06-30 $354,672 21,826
2024-03-31 $251,075 13,579
2023-12-31 $363,978 11,625
2023-09-30 $262,688 12,605
2023-06-30 $340,928 14,235
2023-03-31 $367,366 19,520
2022-12-31 $305,234 19,173
2022-09-30 $237,105 14,493
2022-06-30 $201,205 14,280
2022-03-31 $391,685 16,172
2021-12-31 $377,454 16,172
2021-09-30 $278,798 16,785
2021-06-30 $447,068 18,330
2021-03-31 $309,703 12,004
2020-12-31 $624,145 11,675
2020-09-30 $525,855 12,748
2020-06-30 $565,838 11,674
2020-03-31 $560,911 13,276